Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 18(2): e0279655, 2023.
Article in English | MEDLINE | ID: mdl-36827456

ABSTRACT

Tubulointerstitial fibrosis is observed in diabetic nephropathy. It is still debated whether tubular cells, undergoing epithelial-mesenchymal transition (EMT) in high glucose (HG) conditions, may contribute to interstitial fibrosis development. In this study, we investigated the phenotypic and molecular EMT-like changes and the alteration of inflammatory and fibrogenic secretome induced by HG in human primary tubular cell cultures. Taking advantage of this in vitro cell model composed of proximal and distal tubular cells, we showed that HG-treated tubular cells acquired a fibroblast-like morphology with increased cytoplasmic stress fibers, maintaining the expression of the epithelial markers specific of proximal and distal tubular cells. HG increased Snail1, miRNA210 and Vimentin mesenchymal markers, decreased N-cadherin expression and migration ability of primary tubular cells, while E-cadherin expression and focal adhesion distribution were not affected. Furthermore, HG treatment of tubular cells altered the inflammatory cytokine secretion creating a secretome able to enhance the proliferation and migration of fibroblasts. Our findings show that HG promotes an activated state of partial EMT in human tubular primary cells and induces a pro-inflammatory and pro-fibrogenic microenvironment, supporting the active role of tubular cells in diabetic nephropathy onset.


Subject(s)
Diabetic Nephropathies , Humans , Diabetic Nephropathies/metabolism , Epithelial-Mesenchymal Transition , Epithelial Cells/metabolism , Glucose/metabolism , Fibrosis , Cell Culture Techniques
4.
J Cell Sci ; 129(15): 2925-36, 2016 08 01.
Article in English | MEDLINE | ID: mdl-27298228

ABSTRACT

Renal tubular cells are involved in the tubular interstitial fibrosis observed in diabetic nephropathy. It is debated whether epithelial-mesenchymal transition (EMT) affects tubular cells, which under high-glucose conditions overproduce transforming growth factor-ß (TGF-ß), a fibrogenic cytokine involved in interstitial fibrosis development. Our study investigated the involvement of non-receptor tyrosine kinase Arg (also called Abl2) in TGF-ß production. Human primary tubular cell cultures exposed to high-glucose conditions were used. These cells showed an elongated morphology, stress fibers and vimentin increment but maintained most of the epithelial marker expression and distribution. In these cells exposed to high glucose, which overexpressed and secreted active TGF-ß1, Arg protein and activity was downregulated. A further TGF-ß1 increase was induced by Arg silencing with siRNA, as with the Arg tyrosine kinase inhibitor Imatinib. In the cells exposed to high glucose, reactive oxygen species (ROS)-dependent Arg kinase downregulation induced both RhoA activation, through p190RhoGAPA (also known as ARHGAP35) modulation, and proteasome activity inhibition. These data evidence a new specific involvement of Arg kinase into the regulation of TGF-ß1 expression in tubular cells under high-glucose conditions and provide cues for new translational approaches in diabetic nephropathy.


Subject(s)
Glucose/pharmacology , Kidney Tubules/cytology , Protein-Tyrosine Kinases/metabolism , Transforming Growth Factor beta1/biosynthesis , Adult , Animals , Biomarkers/metabolism , Cell Movement/drug effects , Cells, Cultured , Down-Regulation/drug effects , Epithelial Cells/cytology , Epithelial Cells/metabolism , Epithelial-Mesenchymal Transition/drug effects , Fibroblasts/drug effects , Fibroblasts/metabolism , Gene Silencing/drug effects , Guanine Nucleotide Exchange Factors/metabolism , Humans , Imatinib Mesylate/pharmacology , Mice , NIH 3T3 Cells , Phenotype , Phosphotyrosine/metabolism , Proteasome Inhibitors/pharmacology , Proteolysis/drug effects , Reactive Oxygen Species/metabolism , Stress Fibers/drug effects , Stress Fibers/metabolism , Ubiquitin/metabolism , rhoA GTP-Binding Protein/metabolism
5.
Am J Pathol ; 176(4): 1660-70, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20167856

ABSTRACT

Primary cell cultures from renal cell carcinoma (RCC) and normal renal cortex tissue of 60 patients have been established, with high efficiency (more than 70%) and reproducibility, and extensively characterized. These cultures composed of more than 90% of normal or tumor tubular cells have been instrumental for molecular characterization of Annexin A3 (AnxA3), never extensively studied before in RCC cells although AnxA3 has a prognostic relevance in some cancer and it has been suggested to be involved in the hypoxia-inducible factor-1 pathway. Western blot analysis of 20 matched cortex/RCC culture lysates showed two AnxA3 protein bands of 36 and 33 kDa, and two-dimensional Western blot evidenced several specific protein spots. In RCC cultures the 36-kDa isoform was significantly down-regulated and the 33-kDa isoform up-regulated. Furthermore, the inversion of the quantitative expression pattern of two AnxA3 isoforms in tumor cultures correlate with hypoxia-inducible factor-1alpha expression. The total AnxA3 protein is down-regulated in RCC cultures as confirmed also in tissues by tissue microarray. Two AnxA3 transcripts that differ for alternative splicing of exon III have been also detected. Real-time PCR quantification in 19 matched cortex/RCC cultures confirms the down-regulation of longer isoform in RCC cells. The characteristic expression pattern of AnxA3 in normal and tumor renal cells, documented in our primary cultures, may open new insight in RCC management.


Subject(s)
Annexin A3/biosynthesis , Carcinoma, Renal Cell/metabolism , Gene Expression Regulation, Neoplastic , Kidney Cortex/pathology , Kidney Neoplasms/metabolism , Protein Isoforms , Adult , Aged , Aged, 80 and over , Down-Regulation , Female , Humans , Hypoxia , Kidney Cortex/metabolism , Male , Middle Aged , Prognosis
6.
J Cell Biochem ; 105(5): 1219-27, 2008 Dec 01.
Article in English | MEDLINE | ID: mdl-18810762

ABSTRACT

The human Arg (Abl2) nonreceptor tyrosine kinase has a role in cytoskeletal rearrangements by its C-terminal F-actin- and microtubule-binding sequences. We have previously identified Arg transcripts with different 5'- and 3'-ends, named respectively long and short 1A and 1B (1AL, 1AS, 1BL, 1BS) and long and short C-termini (CTL and CTS), that have different expression patterns in various cell types. The combination of the different ends permits to predict eight putative full-length Arg transcripts and corresponding proteins. By Reverse Transcription-Long PCR we show here that all eight full-length transcripts are endogenously expressed in Caki-1 cells and the two bands, approximately 10 kDa different, shown by 1-D Western blots of Hek293T and Caki-1 lysates correspond to the full-length Arg protein isoforms with different C-termini. 2-D Western blot analysis evidenced different high molecular weight and slight acidic specific spots in Hek293T and Caki-1 lysates. The cellular localization of two Arg isoforms (1BLCTL and 1BLCTS) transfected in Caki-1 and Hek293T cells was cytoplasmic, and some differences in cytoskeleton interactions have been evidenced. Moreover, in Hek293T cells only the transfected 1BLCTS isoform gives rise to a large intracytoplasmic cylindrical structure containing phalloidin-positive amorphous actin aggregates. The presence of eight full-length Arg isoforms with different cellular expression may imply a diverse functional role in normal and neoplastic cells.


Subject(s)
Protein-Tyrosine Kinases/genetics , Cell Line, Tumor , Cells, Cultured , Humans , Isoenzymes/genetics , Isoenzymes/metabolism , Microscopy, Fluorescence , Protein-Tyrosine Kinases/metabolism , Transfection
7.
Eur J Cancer ; 44(7): 1039-47, 2008 May.
Article in English | MEDLINE | ID: mdl-18397824

ABSTRACT

We verified the feasibility of plasma bound method for detecting renal cell carcinoma (RCC) combining the study of plasma DNA concentration and microsatellite alterations (LOH). Plasma DNA concentration was evaluated with real-time PCR in 54 patients with renal neoplasm before surgery and in 20 of these patients during a 26-64 month follow-up. Microsatellite study was performed on tumour tissue DNA of 33 RCC clear cell (RCCcc) and on plasma DNA of 14 RCCcc patients during preoperative and/or follow-up period. Patients had a significantly high (26.4+/-48.3 ng/ml versus controls 3.2+/-1.5 ng/ml; p=0.003) preoperative plasma DNA concentration that decreased after nephrectomy. During follow-up, plasma DNA increased in 12 patients without evidence of neoplasia; 3 patients successively relapsed. Tumour tissue DNA of 25 RCCcc patients (75.8%) displayed microsatellite LOH. Preoperative plasma DNA of 9 patients harboured LOH in 5 cases (55.6%). Augmented plasma DNA of 7 patients displayed LOH in 3 cases (42.9%) at follow-up, and in 1 case preceded the recurrence of disease. Plasma DNA concentration combined with microsatellite LOH in plasma DNA may predict disease recurrence in RCC patients.


Subject(s)
Carcinoma, Renal Cell/diagnosis , DNA, Neoplasm/metabolism , Kidney Neoplasms/diagnosis , Microsatellite Repeats/physiology , Adult , Aged , Aged, 80 and over , Carcinoma, Renal Cell/blood supply , Case-Control Studies , Cell Proliferation , Chromosomes, Human, Pair 3/genetics , DNA, Neoplasm/analysis , Feasibility Studies , Female , Follow-Up Studies , Humans , Kidney Neoplasms/blood supply , Loss of Heterozygosity , Male , Microcirculation , Microsatellite Repeats/genetics , Middle Aged , ROC Curve
SELECTION OF CITATIONS
SEARCH DETAIL
...